25 XP   0   0   10

SCI Pharmtech Inc
Buy, Hold or Sell?

Let's analyse SCI Pharmtech Inc together

PenkeI guess you are interested in SCI Pharmtech Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SCI Pharmtech Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about SCI Pharmtech Inc

I send you an email if I find something interesting about SCI Pharmtech Inc.

Quick analysis of SCI Pharmtech Inc (30 sec.)










What can you expect buying and holding a share of SCI Pharmtech Inc? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
NT$43.03
Expected worth in 1 year
NT$55.18
How sure are you?
92.5%

+ What do you gain per year?

Total Gains per Share
NT$12.16
Return On Investment
13.2%

For what price can you sell your share?

Current Price per Share
NT$91.80
Expected price per share
NT$85.60 - NT$98.00
How sure are you?
50%

1. Valuation of SCI Pharmtech Inc (5 min.)




Live pricePrice per Share (EOD)

NT$91.80

Intrinsic Value Per Share

NT$-129.38 - NT$3.90

Total Value Per Share

NT$-86.35 - NT$46.92

2. Growth of SCI Pharmtech Inc (5 min.)




Is SCI Pharmtech Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$158.8m$111.1m$31.6m22.1%

How much money is SCI Pharmtech Inc making?

Current yearPrevious yearGrowGrow %
Making money$2.1m$2.5m-$426.8k-20.0%
Net Profit Margin22.6%36.7%--

How much money comes from the company's main activities?

3. Financial Health of SCI Pharmtech Inc (5 min.)




What can you expect buying and holding a share of SCI Pharmtech Inc? (5 min.)

Welcome investor! SCI Pharmtech Inc's management wants to use your money to grow the business. In return you get a share of SCI Pharmtech Inc.

What can you expect buying and holding a share of SCI Pharmtech Inc?

First you should know what it really means to hold a share of SCI Pharmtech Inc. And how you can make/lose money.

Speculation

The Price per Share of SCI Pharmtech Inc is NT$91.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of SCI Pharmtech Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in SCI Pharmtech Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$43.03. Based on the TTM, the Book Value Change Per Share is NT$3.04 per quarter. Based on the YOY, the Book Value Change Per Share is NT$0.65 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of SCI Pharmtech Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.010.0%0.020.0%0.040.0%0.020.0%0.020.0%
Usd Book Value Change Per Share0.010.0%0.090.1%0.020.0%0.020.0%0.020.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.030.0%0.040.0%
Usd Total Gains Per Share0.010.0%0.090.1%0.020.0%0.050.1%0.060.1%
Usd Price Per Share2.73-3.20-3.34-3.77-3.45-
Price to Earnings Ratio59.21--160.23-29.07-35.28-38.21-
Price-to-Total Gains Ratio251.30-221.19-196.82-140.29-140.24-
Price to Book Ratio2.05-2.74-3.59-4.05-4.22-
Price-to-Total Gains Ratio251.30-221.19-196.82-140.29-140.24-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.83662
Number of shares352
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.03
Usd Book Value Change Per Share0.090.02
Usd Total Gains Per Share0.090.05
Gains per Quarter (352 shares)33.0518.13
Gains per Year (352 shares)132.2272.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10132122403263
202642548065136
3039738612197209
40529518161129282
50661650201162355
60793782241194428
70926914282226501
8010581046322258574
9011901178362291647
10013221310402323720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%10.02.00.083.3%17.03.00.085.0%37.03.00.092.5%61.03.01.093.8%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%15.05.00.075.0%32.08.00.080.0%50.015.00.076.9%
Dividend per Share0.00.04.00.0%2.00.010.016.7%9.00.011.045.0%24.00.016.060.0%33.00.032.050.8%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%37.03.00.092.5%55.010.00.084.6%

Fundamentals of SCI Pharmtech Inc

About SCI Pharmtech Inc

SCI Pharmtech, Inc. engages in the research and development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and specialty chemicals. Its active pharmaceutical ingredients include Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Divalproex Sodium, Duloxetine HCl, Hydroxychloroquine sulfate, Loxoprofen Sodium, Methylphenidate HCl, Pentobarbital Sodium, Probucol, Propafenone HCl, Sodium Valproate, Thiopental, Valproic Acid, Adenine, Cannabidiol, and Dexmethylphenidate HCl. The company's intermediate products comprise Azetidin-3-ol hydrogenchloride, Diethyl Isobutyl Malonate, Diethyl dipropylmalonate, Diethyl ethyl(1-methylbutyl)malonate, Pyrogallolaldehyde, Benzhydrylamine, 1-Benzhydrylazetidin-3-ol, 1-(2-Hydroxyphenyl)-3-phenylpropan-1-one, N-Methyl-4-piperidinol, Ritalinic acid, d-Ritalinic acid HCl, (1R, 2S)-1 Phenyl-2-(pyrrolldin-1-yl)propan-1-ol HCl, and (1R, 2S)-1 Phenyl-2-(pyrrolldin-1-yl)propan-1-ol. Its intermediate products also consists of (S)-3-(methylmino)-1-(2-thi-enyl)propan-1-ol, (R)-3-(Methylamino)-1-phenylpropanol, (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol, Menthadienol, 5-pentylbenzene-1,3-diol Olivetol, Methyl 2,4-dihydroxy-6-pentylbenzoate, and Ethyl 2,4-dihydroxy-6-pentylbenzoate Ethyl Olivetolate. The company also provides custom manufacturing services. It sells its products in Italy, China, the United States, Germany, Taiwan, Switzerland, Spain, Japan, the Netherlands, and internationally. The company was incorporated in 1987 and is based in Taoyuan City, Taiwan.

Fundamental data was last updated by Penke on 2024-05-11 20:22:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of SCI Pharmtech Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit SCI Pharmtech Inc earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare SCI Pharmtech Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 14.4% means that NT$0.14 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SCI Pharmtech Inc:

  • The MRQ is 14.4%. The company is making a huge profit. +2
  • The TTM is 22.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.4%TTM22.6%-8.3%
TTM22.6%YOY36.7%-14.0%
TTM22.6%5Y18.7%+4.0%
5Y18.7%10Y19.2%-0.5%
1.1.2. Return on Assets

Shows how efficient SCI Pharmtech Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare SCI Pharmtech Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.7% Return on Assets means that SCI Pharmtech Inc generated NT$0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SCI Pharmtech Inc:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.7%TTM1.2%-0.6%
TTM1.2%YOY1.7%-0.5%
TTM1.2%5Y1.6%-0.4%
5Y1.6%10Y2.1%-0.5%
1.1.3. Return on Equity

Shows how efficient SCI Pharmtech Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare SCI Pharmtech Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.9% Return on Equity means SCI Pharmtech Inc generated NT$0.01 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SCI Pharmtech Inc:

  • The MRQ is 0.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.9%TTM1.6%-0.8%
TTM1.6%YOY2.3%-0.7%
TTM1.6%5Y2.0%-0.4%
5Y2.0%10Y2.6%-0.6%

1.2. Operating Efficiency of SCI Pharmtech Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient SCI Pharmtech Inc is operating .

  • Measures how much profit SCI Pharmtech Inc makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare SCI Pharmtech Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SCI Pharmtech Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.9%-2.9%
TTM2.9%YOY11.8%-8.8%
TTM2.9%5Y17.8%-14.9%
5Y17.8%10Y14.6%+3.2%
1.2.2. Operating Ratio

Measures how efficient SCI Pharmtech Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.56 means that the operating costs are NT$1.56 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of SCI Pharmtech Inc:

  • The MRQ is 1.558. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.619. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.558TTM1.619-0.060
TTM1.619YOY1.499+0.119
TTM1.6195Y1.480+0.139
5Y1.48010Y1.222+0.258

1.3. Liquidity of SCI Pharmtech Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if SCI Pharmtech Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 4.13 means the company has NT$4.13 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of SCI Pharmtech Inc:

  • The MRQ is 4.127. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.853. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ4.127TTM2.853+1.274
TTM2.853YOY1.424+1.429
TTM2.8535Y2.285+0.567
5Y2.28510Y1.969+0.317
1.3.2. Quick Ratio

Measures if SCI Pharmtech Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare SCI Pharmtech Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.71 means the company can pay off NT$0.71 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SCI Pharmtech Inc:

  • The MRQ is 0.711. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.678. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.711TTM0.678+0.033
TTM0.678YOY0.425+0.253
TTM0.6785Y0.906-0.228
5Y0.90610Y0.753+0.153

1.4. Solvency of SCI Pharmtech Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of SCI Pharmtech Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare SCI Pharmtech Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.23 means that SCI Pharmtech Inc assets are financed with 23.2% credit (debt) and the remaining percentage (100% - 23.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SCI Pharmtech Inc:

  • The MRQ is 0.232. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.242. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.232TTM0.242-0.010
TTM0.242YOY0.255-0.013
TTM0.2425Y0.223+0.019
5Y0.22310Y0.211+0.012
1.4.2. Debt to Equity Ratio

Measures if SCI Pharmtech Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare SCI Pharmtech Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 30.3% means that company has NT$0.30 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SCI Pharmtech Inc:

  • The MRQ is 0.303. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.320. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.303TTM0.320-0.017
TTM0.320YOY0.345-0.025
TTM0.3205Y0.291+0.029
5Y0.29110Y0.275+0.016

2. Market Valuation of SCI Pharmtech Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings SCI Pharmtech Inc generates.

  • Above 15 is considered overpriced but always compare SCI Pharmtech Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 59.21 means the investor is paying NT$59.21 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SCI Pharmtech Inc:

  • The EOD is 61.622. Based on the earnings, the company is expensive. -2
  • The MRQ is 59.205. Based on the earnings, the company is expensive. -2
  • The TTM is -160.231. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD61.622MRQ59.205+2.417
MRQ59.205TTM-160.231+219.437
TTM-160.231YOY29.066-189.298
TTM-160.2315Y35.278-195.509
5Y35.27810Y38.214-2.937
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SCI Pharmtech Inc:

  • The EOD is -120.158. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -115.446. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -29.426. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-120.158MRQ-115.446-4.712
MRQ-115.446TTM-29.426-86.020
TTM-29.426YOY-6.379-23.048
TTM-29.4265Y16.752-46.178
5Y16.75210Y-52.902+69.653
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of SCI Pharmtech Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.05 means the investor is paying NT$2.05 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of SCI Pharmtech Inc:

  • The EOD is 2.134. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.050. Based on the equity, the company is underpriced. +1
  • The TTM is 2.741. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.134MRQ2.050+0.084
MRQ2.050TTM2.741-0.691
TTM2.741YOY3.587-0.846
TTM2.7415Y4.053-1.312
5Y4.05310Y4.216-0.163
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of SCI Pharmtech Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3513.039-88%0.647-46%0.742-53%0.630-44%
Book Value Per Share--43.02538.658+11%30.099+43%30.836+40%27.129+59%
Current Ratio--4.1272.853+45%1.424+190%2.285+81%1.969+110%
Debt To Asset Ratio--0.2320.242-4%0.255-9%0.223+4%0.211+10%
Debt To Equity Ratio--0.3030.320-5%0.345-12%0.291+4%0.275+10%
Dividend Per Share----0%-0%0.924-100%1.261-100%
Eps--0.3720.577-35%1.230-70%0.723-48%0.737-49%
Free Cash Flow Per Share---0.191-0.804+321%-1.436+652%-0.451+136%0.235-181%
Free Cash Flow To Equity Per Share---0.191-1.292+576%-0.120-37%-0.489+156%-0.199+4%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.899--------
Intrinsic Value_10Y_min---129.379--------
Intrinsic Value_1Y_max--0.862--------
Intrinsic Value_1Y_min---7.769--------
Intrinsic Value_3Y_max--2.231--------
Intrinsic Value_3Y_min---27.982--------
Intrinsic Value_5Y_max--3.166--------
Intrinsic Value_5Y_min---53.123--------
Market Cap10970926200.000+4%10540693800.00012369554965.625-15%12933861525.000-19%14588179796.125-28%13355365286.413-21%
Net Profit Margin--0.1440.226-37%0.367-61%0.187-23%0.192-25%
Operating Margin---0.029-100%0.118-100%0.178-100%0.146-100%
Operating Ratio--1.5581.619-4%1.499+4%1.480+5%1.222+28%
Pb Ratio2.134+4%2.0502.741-25%3.587-43%4.053-49%4.216-51%
Pe Ratio61.622+4%59.205-160.231+371%29.066+104%35.278+68%38.214+55%
Price Per Share91.800+4%88.200103.503-15%108.225-19%122.068-28%111.752-21%
Price To Free Cash Flow Ratio-120.158-4%-115.446-29.426-75%-6.379-94%16.752-789%-52.902-54%
Price To Total Gains Ratio261.555+4%251.298221.194+14%196.819+28%140.288+79%140.243+79%
Quick Ratio--0.7110.678+5%0.425+67%0.906-21%0.753-6%
Return On Assets--0.0070.012-46%0.017-62%0.016-59%0.021-68%
Return On Equity--0.0090.016-47%0.023-63%0.020-57%0.026-67%
Total Gains Per Share--0.3513.039-88%0.647-46%1.667-79%1.890-81%
Usd Book Value--158884648.200142757235.225+11%111150760.800+43%113873123.415+40%100182143.768+59%
Usd Book Value Change Per Share--0.0110.094-88%0.020-46%0.023-53%0.019-44%
Usd Book Value Per Share--1.3291.195+11%0.930+43%0.953+40%0.838+59%
Usd Dividend Per Share----0%-0%0.029-100%0.039-100%
Usd Eps--0.0120.018-35%0.038-70%0.022-48%0.023-49%
Usd Free Cash Flow---705323.400-2968292.625+321%-5303676.000+652%-1664238.465+136%868095.330-181%
Usd Free Cash Flow Per Share---0.006-0.025+321%-0.044+652%-0.014+136%0.007-181%
Usd Free Cash Flow To Equity Per Share---0.006-0.040+576%-0.004-37%-0.015+156%-0.006+4%
Usd Market Cap339001619.580+4%325707438.420382219248.438-15%399656321.123-19%450774755.700-28%412680787.350-21%
Usd Price Per Share2.837+4%2.7253.198-15%3.344-19%3.772-28%3.453-21%
Usd Profit--1375328.1002130493.200-35%2557322.625-46%2272517.325-39%2522393.265-45%
Usd Revenue--9575261.1009055700.775+6%8138241.150+18%11926279.875-20%12664994.588-24%
Usd Total Gains Per Share--0.0110.094-88%0.020-46%0.052-79%0.058-81%
 EOD+5 -3MRQTTM+18 -15YOY+15 -185Y+13 -2210Y+10 -25

3.2. Fundamental Score

Let's check the fundamental score of SCI Pharmtech Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1561.622
Price to Book Ratio (EOD)Between0-12.134
Net Profit Margin (MRQ)Greater than00.144
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.711
Current Ratio (MRQ)Greater than14.127
Debt to Asset Ratio (MRQ)Less than10.232
Debt to Equity Ratio (MRQ)Less than10.303
Return on Equity (MRQ)Greater than0.150.009
Return on Assets (MRQ)Greater than0.050.007
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of SCI Pharmtech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose91.400
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets6,698,858
Total Liabilities1,556,960
Total Stockholder Equity5,141,898
 As reported
Total Liabilities 1,556,960
Total Stockholder Equity+ 5,141,898
Total Assets = 6,698,858

Assets

Total Assets6,698,858
Total Current Assets1,923,866
Long-term Assets4,774,992
Total Current Assets
Cash And Cash Equivalents 915,963
Short-term Investments 78,399
Net Receivables 253,031
Inventory 601,181
Other Current Assets 75,049
Total Current Assets  (as reported)1,923,866
Total Current Assets  (calculated)1,923,623
+/- 243
Long-term Assets
Property Plant Equipment 3,920,911
Long-term Assets Other 193,808
Long-term Assets  (as reported)4,774,992
Long-term Assets  (calculated)4,114,719
+/- 660,273

Liabilities & Shareholders' Equity

Total Current Liabilities466,165
Long-term Liabilities1,090,795
Total Stockholder Equity5,141,898
Total Current Liabilities
Short Long Term Debt 112,831
Accounts payable 77,385
Other Current Liabilities 15,605
Total Current Liabilities  (as reported)466,165
Total Current Liabilities  (calculated)205,821
+/- 260,344
Long-term Liabilities
Long term Debt 912,706
Capital Lease Obligations Min Short Term Debt4,304
Long-term Liabilities Other 1,000
Long-term Liabilities  (as reported)1,090,795
Long-term Liabilities  (calculated)918,010
+/- 172,785
Total Stockholder Equity
Retained Earnings 1,173,166
Total Stockholder Equity (as reported)5,141,898
Total Stockholder Equity (calculated)1,173,166
+/- 3,968,732
Other
Capital Stock1,195,087
Common Stock Shares Outstanding 119,509
Net Debt 109,574
Net Invested Capital 6,167,435
Net Working Capital 1,457,701
Property Plant and Equipment Gross 3,920,911



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-06-302006-09-302006-03-312005-09-302005-06-302004-06-302003-06-30
> Total Assets 
837,508
878,345
884,203
829,352
869,536
887,358
964,403
1,099,392
1,154,023
1,173,818
1,132,662
1,197,120
1,259,382
1,192,767
1,252,158
1,367,134
1,448,222
1,461,822
1,504,607
1,471,664
1,510,138
1,534,845
1,516,465
1,473,804
1,493,646
1,487,352
2,141,674
2,221,130
2,868,000
3,052,597
3,119,381
3,274,669
3,168,717
3,220,876
3,289,076
3,446,767
3,293,880
3,457,085
3,629,672
3,736,224
3,438,802
3,550,347
3,532,937
3,589,128
3,256,987
3,295,631
3,389,284
3,638,416
3,698,211
3,789,079
3,973,210
4,138,398
3,953,235
4,081,477
4,310,334
4,638,817
4,248,645
4,569,938
4,458,491
4,253,791
4,260,204
4,189,895
4,399,833
4,567,013
4,618,383
4,960,539
5,216,361
5,415,671
5,555,503
6,690,741
6,698,858
6,698,8586,690,7415,555,5035,415,6715,216,3614,960,5394,618,3834,567,0134,399,8334,189,8954,260,2044,253,7914,458,4914,569,9384,248,6454,638,8174,310,3344,081,4773,953,2354,138,3983,973,2103,789,0793,698,2113,638,4163,389,2843,295,6313,256,9873,589,1283,532,9373,550,3473,438,8023,736,2243,629,6723,457,0853,293,8803,446,7673,289,0763,220,8763,168,7173,274,6693,119,3813,052,5972,868,0002,221,1302,141,6741,487,3521,493,6461,473,8041,516,4651,534,8451,510,1381,471,6641,504,6071,461,8221,448,2221,367,1341,252,1581,192,7671,259,3821,197,1201,132,6621,173,8181,154,0231,099,392964,403887,358869,536829,352884,203878,345837,508
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,622,963
1,597,672
1,664,762
1,318,214
1,338,784
1,421,124
1,680,472
1,636,219
1,706,919
1,888,964
2,043,276
1,820,919
1,936,018
2,182,380
2,481,753
1,421,759
1,918,811
1,781,135
2,014,844
1,771,050
1,397,310
1,270,368
1,317,601
1,070,010
1,042,398
1,033,719
1,090,711
1,111,421
1,953,239
1,923,866
1,923,8661,953,2391,111,4211,090,7111,033,7191,042,3981,070,0101,317,6011,270,3681,397,3101,771,0502,014,8441,781,1351,918,8111,421,7592,481,7532,182,3801,936,0181,820,9192,043,2761,888,9641,706,9191,636,2191,680,4721,421,1241,338,7841,318,2141,664,7621,597,6721,622,96300000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
326,777
331,827
268,247
148,076
255,869
272,377
374,539
332,289
361,181
576,686
571,922
391,598
553,555
656,467
778,055
478,006
633,029
811,372
427,889
427,690
332,231
173,454
404,282
244,821
166,828
99,605
143,703
140,515
942,057
915,963
915,963942,057140,515143,70399,605166,828244,821404,282173,454332,231427,690427,889811,372633,029478,006778,055656,467553,555391,598571,922576,686361,181332,289374,539272,377255,869148,076268,247331,827326,77700000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
434,873
473,979
435,951
466,025
557,168
661,063
0
0
0
624,375
595,821
360,401
233,453
131,275
99,104
97,545
97,401
89,283
90,744
88,998
78,399
78,39988,99890,74489,28397,40197,54599,104131,275233,453360,401595,821624,375000661,063557,168466,025435,951473,979434,87300000000000000000000000000000000000000000000000000
       Net Receivables 
111,830
114,907
91,051
98,976
108,910
128,362
157,852
276,697
230,646
226,230
220,559
208,456
182,458
197,270
193,823
215,067
239,795
199,644
203,145
175,570
190,782
202,951
205,959
209,511
227,218
183,761
434,739
215,530
225,668
216,304
223,463
203,498
222,236
245,799
252,096
344,460
329,397
171,008
375,027
370,462
345,889
252,683
185,881
223,471
273,510
173,702
258,867
386,468
384,560
390,917
332,843
459,668
491,578
352,404
504,456
494,115
449,346
856,806
673,900
662,469
426,611
348,562
440,032
255,578
227,371
173,565
254,671
287,091
278,745
307,369
253,031
253,031307,369278,745287,091254,671173,565227,371255,578440,032348,562426,611662,469673,900856,806449,346494,115504,456352,404491,578459,668332,843390,917384,560386,468258,867173,702273,510223,471185,881252,683345,889370,462375,027171,008329,397344,460252,096245,799222,236203,498223,463216,304225,668215,530434,739183,761227,218209,511205,959202,951190,782175,570203,145199,644239,795215,067193,823197,270182,458208,456220,559226,230230,646276,697157,852128,362108,91098,97691,051114,907111,830
       Inventory 
0
0
0
122,822
122,684
125,889
0
0
144,311
208,267
180,829
138,396
198,666
214,166
208,285
203,311
226,058
231,339
260,212
278,965
276,262
277,735
310,800
244,890
254,863
244,381
322,176
342,667
354,936
406,841
406,463
461,404
464,529
510,021
500,939
478,763
472,279
553,998
522,407
486,620
428,029
498,357
482,728
518,902
492,662
482,825
449,464
471,730
461,176
503,072
517,593
519,388
484,733
527,081
423,545
523,808
475,961
380,879
247,549
249,778
263,312
294,182
348,130
462,589
427,809
513,430
521,057
487,442
519,079
529,533
601,181
601,181529,533519,079487,442521,057513,430427,809462,589348,130294,182263,312249,778247,549380,879475,961523,808423,545527,081484,733519,388517,593503,072461,176471,730449,464482,825492,662518,902482,728498,357428,029486,620522,407553,998472,279478,763500,939510,021464,529461,404406,463406,841354,936342,667322,176244,381254,863244,890310,800277,735276,262278,965260,212231,339226,058203,311208,285214,166198,666138,396180,829208,267144,31100125,889122,684122,822000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,084,246
2,095,122
2,132,316
2,145,459
2,127,954
2,157,064
2,826,886
2,651,127
2,677,356
2,238,947
2,489,154
2,792,585
3,129,465
3,249,412
3,548,373
3,918,141
4,182,642
4,324,960
4,444,082
4,737,502
4,774,992
4,774,9924,737,5024,444,0824,324,9604,182,6423,918,1413,548,3733,249,4123,129,4652,792,5852,489,1542,238,9472,677,3562,651,1272,826,8862,157,0642,127,9542,145,4592,132,3162,095,1222,084,24600000000000000000000000000000000000000000000000000
       Property Plant Equipment 
506,777
492,875
457,627
456,172
474,828
520,840
597,780
636,999
656,521
650,740
670,986
666,678
691,783
718,388
745,024
743,407
777,098
819,429
828,661
829,409
835,079
857,974
869,125
876,942
896,101
913,125
1,173,200
1,366,656
1,513,846
1,554,940
1,618,978
1,689,135
1,738,429
1,775,857
1,766,151
1,765,961
1,794,911
1,785,437
1,765,331
1,787,264
1,777,152
1,762,038
1,734,972
1,724,577
1,748,970
1,741,102
1,725,944
1,683,922
1,754,735
1,745,986
1,883,771
1,876,012
1,878,220
1,879,973
1,887,048
1,898,354
1,886,397
1,502,720
1,517,060
1,587,787
1,652,951
2,100,131
2,362,863
2,576,241
2,806,314
3,194,157
3,449,845
3,451,462
3,704,740
3,911,765
3,920,911
3,920,9113,911,7653,704,7403,451,4623,449,8453,194,1572,806,3142,576,2412,362,8632,100,1311,652,9511,587,7871,517,0601,502,7201,886,3971,898,3541,887,0481,879,9731,878,2201,876,0121,883,7711,745,9861,754,7351,683,9221,725,9441,741,1021,748,9701,724,5771,734,9721,762,0381,777,1521,787,2641,765,3311,785,4371,794,9111,765,9611,766,1511,775,8571,738,4291,689,1351,618,9781,554,9401,513,8461,366,6561,173,200913,125896,101876,942869,125857,974835,079829,409828,661819,429777,098743,407745,024718,388691,783666,678670,986650,740656,521636,999597,780520,840474,828456,172457,627492,875506,777
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42,366
42,366
42,366
42,366
42,366
41,827
41,422
45,514
75,296
68,219
85,312
121,879
137,329
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000137,329121,87985,31268,21975,29645,51441,42241,82742,36642,36642,36642,36642,36600000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
257
0
257
10,364
10,292
10,671
10,500
9,919
10,063
9,939
10,664
10,608
10,338
10,379
10,274
92
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,047
33,594
45,548
47,669
47,368
48,865
49,541
49,117
47,661
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000047,66149,11749,54148,86547,36847,66945,54833,5941,0470000000000000000009210,27410,37910,33810,60810,6649,93910,0639,91910,50010,67110,29210,364257025700000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,159
33,025
31,868
23,253
34,729
45,245
71,828
89,890
119,842
207,624
374,761
265,644
325,941
245,467
85,677
66,098
82,533
30,349
33,631
156,679
193,808
193,808156,67933,63130,34982,53366,09885,677245,467325,941265,644374,761207,624119,84289,89071,82845,24534,72923,25331,86833,02532,15900000000000000000000000000000000000000000000000000
> Total Liabilities 
128,992
134,716
146,693
73,717
93,800
120,805
170,183
169,723
283,438
255,152
190,155
195,680
305,352
190,947
214,320
284,445
401,573
373,039
373,373
292,250
393,221
374,265
385,260
285,295
347,911
292,624
839,751
1,003,850
838,707
984,623
987,023
1,178,150
989,798
994,636
966,231
1,004,200
697,818
695,016
705,425
804,230
401,425
479,426
410,137
759,817
386,784
365,883
397,474
668,766
597,588
578,848
606,010
945,208
563,650
606,837
661,964
1,198,985
617,438
1,247,716
1,112,082
913,727
910,069
869,264
1,020,180
1,055,060
1,060,263
1,331,315
1,527,210
1,306,444
1,426,680
1,590,788
1,556,960
1,556,9601,590,7881,426,6801,306,4441,527,2101,331,3151,060,2631,055,0601,020,180869,264910,069913,7271,112,0821,247,716617,4381,198,985661,964606,837563,650945,208606,010578,848597,588668,766397,474365,883386,784759,817410,137479,426401,425804,230705,425695,016697,8181,004,200966,231994,636989,7981,178,150987,023984,623838,7071,003,850839,751292,624347,911285,295385,260374,265393,221292,250373,373373,039401,573284,445214,320190,947305,352195,680190,155255,152283,438169,723170,183120,80593,80073,717146,693134,716128,992
   > Total Current Liabilities 
107,608
127,376
145,952
72,591
93,051
120,073
169,509
169,628
283,227
254,953
188,759
194,051
303,486
188,849
208,705
278,533
395,355
366,509
365,079
283,624
384,269
364,987
372,270
271,933
334,202
278,536
807,382
971,470
246,270
391,429
402,870
590,788
398,923
396,559
366,995
624,498
676,575
672,907
683,359
782,225
379,473
455,398
386,590
735,486
363,083
342,973
374,688
646,075
575,090
556,711
582,243
922,016
540,957
584,264
639,976
1,177,402
595,188
1,122,214
987,109
788,664
785,657
747,937
789,488
771,763
722,105
770,315
896,225
584,941
558,092
569,887
466,165
466,165569,887558,092584,941896,225770,315722,105771,763789,488747,937785,657788,664987,1091,122,214595,1881,177,402639,976584,264540,957922,016582,243556,711575,090646,075374,688342,973363,083735,486386,590455,398379,473782,225683,359672,907676,575624,498366,995396,559398,923590,788402,870391,429246,270971,470807,382278,536334,202271,933372,270364,987384,269283,624365,079366,509395,355278,533208,705188,849303,486194,051188,759254,953283,227169,628169,509120,07393,05172,591145,952127,376107,608
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,878
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001,87800000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,878
0
0
0
0
0
0
0
0
0
0
0
243,000
58,000
0
112,000
425,000
105,000
140,000
195,000
112,831
112,831195,000140,000105,000425,000112,000058,000243,000000000000001,87800000000000000000000000000000000000000000000000000
       Accounts payable 
21,594
18,692
27,608
20,292
23,051
39,732
38,351
39,721
52,842
68,878
25,411
36,590
46,902
31,284
47,723
48,139
49,337
53,034
61,301
43,937
50,570
61,552
71,647
45,095
49,102
52,823
66,524
65,166
83,722
82,007
74,524
103,731
65,919
79,591
87,443
81,968
73,872
67,417
60,249
46,123
47,592
58,045
49,433
56,426
47,498
35,180
74,054
88,844
90,381
89,156
102,251
105,081
71,694
94,302
70,115
119,258
86,305
80,878
20,132
27,920
24,511
33,779
45,095
52,357
40,121
48,636
46,815
36,693
31,669
44,251
77,385
77,38544,25131,66936,69346,81548,63640,12152,35745,09533,77924,51127,92020,13280,87886,305119,25870,11594,30271,694105,081102,25189,15690,38188,84474,05435,18047,49856,42649,43358,04547,59246,12360,24967,41773,87281,96887,44379,59165,919103,73174,52482,00783,72265,16666,52452,82349,10245,09571,64761,55250,57043,93761,30153,03449,33748,13947,72331,28446,90236,59025,41168,87852,84239,72138,35139,73223,05120,29227,60818,69221,594
       Other Current Liabilities 
39,850
55,211
65,845
28,662
36,626
43,584
101,881
102,078
190,851
119,561
141,163
155,763
223,819
127,655
160,982
133,394
212,859
106,475
128,778
118,886
227,948
120,927
124,705
123,338
204,100
141,925
188,707
335,331
155,647
203,422
253,346
367,057
201,004
266,968
279,552
542,530
602,703
605,490
623,110
716,102
331,881
397,353
337,157
679,060
315,585
307,793
300,634
375,871
300,018
259,475
55
2,151
183
251,443
339,734
769,394
260,234
835,238
798,676
613,951
612,162
591,116
407,593
542,149
567,202
5,224
423,925
441,730
10,570
11,351
15,605
15,60511,35110,570441,730423,9255,224567,202542,149407,593591,116612,162613,951798,676835,238260,234769,394339,734251,4431832,15155259,475300,018375,871300,634307,793315,585679,060337,157397,353331,881716,102623,110605,490602,703542,530279,552266,968201,004367,057253,346203,422155,647335,331188,707141,925204,100123,338124,705120,927227,948118,886128,778106,475212,859133,394160,982127,655223,819155,763141,163119,561190,851102,078101,88143,58436,62628,66265,84555,21139,850
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,767
23,192
22,693
22,573
21,988
21,583
22,250
125,502
124,973
125,063
124,412
121,327
230,692
283,297
338,158
561,000
630,985
721,503
868,588
1,020,901
1,090,795
1,090,7951,020,901868,588721,503630,985561,000338,158283,297230,692121,327124,412125,063124,973125,50222,25021,58321,98822,57322,69323,19223,76700000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,770
3,181
2,713
2,992
2,496
1,998
3,104
2,588
2,031
2,975
2,566
2,155
1,743
1,329
914
1,023
616
4,827
5,300
4,804
4,304
4,3044,8045,3004,8276161,0239141,3291,7432,1552,5662,9752,0312,5883,1041,9982,4962,9922,7133,1811,77000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,802
0
0
0
20,963
0
0
0
0
0
0
0
0
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,0001,0001,0001,0001,0001,0001,0000000000020,96300021,802000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
708,516
743,629
737,510
755,635
775,736
766,553
794,220
929,669
870,585
918,666
942,507
1,001,440
954,030
1,001,820
1,037,838
1,082,689
1,046,649
1,088,783
1,131,234
1,179,414
1,116,917
1,160,580
1,131,205
1,188,509
1,145,735
1,194,728
1,301,923
1,217,280
2,029,293
2,067,974
2,132,358
2,096,519
2,178,919
2,226,240
2,322,845
2,442,567
2,596,062
2,762,069
2,924,247
2,931,994
3,037,377
3,070,921
3,122,800
2,829,311
2,870,203
2,929,748
2,991,810
2,969,650
3,100,623
3,210,231
3,367,200
3,193,190
3,389,585
3,474,640
3,648,370
3,439,832
3,631,207
3,322,222
3,346,409
3,340,064
3,350,135
3,320,631
3,379,653
3,511,953
3,558,120
3,629,224
3,689,151
4,109,227
4,128,823
5,099,953
5,141,898
5,141,8985,099,9534,128,8234,109,2273,689,1513,629,2243,558,1203,511,9533,379,6533,320,6313,350,1353,340,0643,346,4093,322,2223,631,2073,439,8323,648,3703,474,6403,389,5853,193,1903,367,2003,210,2313,100,6232,969,6502,991,8102,929,7482,870,2032,829,3113,122,8003,070,9213,037,3772,931,9942,924,2472,762,0692,596,0622,442,5672,322,8452,226,2402,178,9192,096,5192,132,3582,067,9742,029,2931,217,2801,301,9231,194,7281,145,7351,188,5091,131,2051,160,5801,116,9171,179,4141,131,2341,088,7831,046,6491,082,6891,037,8381,001,820954,0301,001,440942,507918,666870,585929,669794,220766,553775,736755,635737,510743,629708,516
   Common Stock
301,290
301,290
325,107
325,107
325,107
325,107
325,107
325,107
325,107
361,617
361,617
361,617
361,617
401,212
404,622
405,822
405,822
451,901
452,671
452,671
452,671
491,663
491,663
491,913
491,913
492,823
493,173
493,423
657,001
657,061
662,061
662,061
696,905
696,525
696,846
733,431
743,007
762,177
762,896
793,115
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
794,853
953,824
953,824
953,824
953,824
953,824
0
953,824
953,824
0
0
0
000953,824953,8240953,824953,824953,824953,824953,824794,853794,853794,853794,853794,853794,853794,853794,853794,853794,853794,853794,853794,853794,853794,853794,853794,853794,853794,853794,853793,115762,896762,177743,007733,431696,846696,525696,905662,061662,061657,061657,001493,423493,173492,823491,913491,913491,663491,663452,671452,671452,671451,901405,822405,822404,622401,212361,617361,617361,617361,617325,107325,107325,107325,107325,107325,107325,107301,290301,290
   Retained Earnings 
285,848
288,424
278,127
296,252
316,353
303,193
326,263
461,712
387,576
397,738
425,349
483,355
416,593
401,575
437,550
478,839
422,108
399,391
443,185
490,838
409,884
393,784
362,287
419,156
364,261
411,101
633,599
508,594
531,372
570,442
634,047
576,104
636,782
681,623
774,440
670,307
765,509
825,442
982,378
809,435
903,864
936,812
988,214
694,485
735,137
794,443
856,884
835,129
962,010
1,071,827
939,898
722,005
881,833
1,309,194
1,517,525
1,298,181
1,487,097
1,208,408
1,250,081
1,253,832
1,085,038
1,067,397
1,108,570
1,248,912
1,297,528
892,197
955,635
1,538,947
1,124,227
1,128,657
1,173,166
1,173,1661,128,6571,124,2271,538,947955,635892,1971,297,5281,248,9121,108,5701,067,3971,085,0381,253,8321,250,0811,208,4081,487,0971,298,1811,517,5251,309,194881,833722,005939,8981,071,827962,010835,129856,884794,443735,137694,485988,214936,812903,864809,435982,378825,442765,509670,307774,440681,623636,782576,104634,047570,442531,372508,594633,599411,101364,261419,156362,287393,784409,884490,838443,185399,391422,108478,839437,550401,575416,593483,355425,349397,738387,576461,712326,263303,193316,353296,252278,127288,424285,848
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-9,083
-8,606
-8,366
-8,126
-7,887
-8,266
-8,671
-4,579
-4,788
-11,865
-9,766
26,801
22,254
-12,347
-1,541
918
-29,378
-46,864
-56,960
-37,066
-48,929
-31,080
-39,122
-41,571
0
-58,238
259,329
0
0
0
000259,329-58,2380-41,571-39,122-31,080-48,929-37,066-56,960-46,864-29,378918-1,541-12,34722,25426,801-9,766-11,865-4,788-4,579-8,671-8,266-7,887-8,126-8,366-8,606-9,08300000000000000000000000000000000000000000



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,204,159
Cost of Revenue-853,836
Gross Profit350,323350,323
 
Operating Income (+$)
Gross Profit350,323
Operating Expense-1,043,859
Operating Income160,300-693,536
 
Operating Expense (+$)
Research Development49,094
Selling General Administrative140,929
Selling And Marketing Expenses0
Operating Expense1,043,859190,023
 
Net Interest Income (+$)
Interest Income3,447
Interest Expense-6,290
Other Finance Cost-0
Net Interest Income-2,843
 
Pretax Income (+$)
Operating Income160,300
Net Interest Income-2,843
Other Non-Operating Income Expenses0
Income Before Tax (EBT)364,190160,300
EBIT - interestExpense = -6,290
294,721
301,011
Interest Expense6,290
Earnings Before Interest and Taxes (EBIT)0370,480
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax364,190
Tax Provision-69,469
Net Income From Continuing Ops294,721294,721
Net Income294,721
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,843
 

Technical Analysis of SCI Pharmtech Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of SCI Pharmtech Inc. The general trend of SCI Pharmtech Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine SCI Pharmtech Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of SCI Pharmtech Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 93.30 < 96.30 < 98.00.

The bearish price targets are: 90.00 > 89.80 > 85.60.

Tweet this
SCI Pharmtech Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of SCI Pharmtech Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

SCI Pharmtech Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of SCI Pharmtech Inc.

SCI Pharmtech Inc Daily Moving Average Convergence/Divergence (MACD) ChartSCI Pharmtech Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of SCI Pharmtech Inc. The current adx is .

SCI Pharmtech Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of SCI Pharmtech Inc.

SCI Pharmtech Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of SCI Pharmtech Inc.

SCI Pharmtech Inc Daily Relative Strength Index (RSI) ChartSCI Pharmtech Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of SCI Pharmtech Inc.

SCI Pharmtech Inc Daily Stochastic Oscillator ChartSCI Pharmtech Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of SCI Pharmtech Inc.

SCI Pharmtech Inc Daily Commodity Channel Index (CCI) ChartSCI Pharmtech Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of SCI Pharmtech Inc.

SCI Pharmtech Inc Daily Chande Momentum Oscillator (CMO) ChartSCI Pharmtech Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of SCI Pharmtech Inc.

SCI Pharmtech Inc Daily Williams %R ChartSCI Pharmtech Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of SCI Pharmtech Inc.

SCI Pharmtech Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of SCI Pharmtech Inc.

SCI Pharmtech Inc Daily Average True Range (ATR) ChartSCI Pharmtech Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of SCI Pharmtech Inc.

SCI Pharmtech Inc Daily On-Balance Volume (OBV) ChartSCI Pharmtech Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of SCI Pharmtech Inc.

SCI Pharmtech Inc Daily Money Flow Index (MFI) ChartSCI Pharmtech Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for SCI Pharmtech Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-05-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

SCI Pharmtech Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of SCI Pharmtech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose91.400
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of SCI Pharmtech Inc with someone you think should read this too:
  • Are you bullish or bearish on SCI Pharmtech Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about SCI Pharmtech Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about SCI Pharmtech Inc

I send you an email if I find something interesting about SCI Pharmtech Inc.


Comments

How you think about this?

Leave a comment

Stay informed about SCI Pharmtech Inc.

Receive notifications about SCI Pharmtech Inc in your mailbox!